Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)
The expanded access program for TAK-113 in adults with metastatic colorectal cancer is no longer available.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors [Phase 1, Phase 2]
A clinical trial evaluating Revumenib in colorectal cancer and other solid tumors has completed Phase 1 and Phase 2. The sponsor is Syndax P…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. [Phase 1, Phase 2]
Phase 1/2a trial evaluating WEF-001 as monotherapy for safety, tolerability, pharmacokinetics, and preliminary efficacy in advanced KRAS-mut…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy [Phase 1, Phase 2]
A Phase 1/2 trial of CHM-2101, an autologous CDH17 CAR-T therapy, is evaluating safety and early efficacy in neuroendocrine tumors, colorect…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating TGI-5 as a monotherapy and in combination with nivolumab in locally advanced or metastatic solid tumors; recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Reducing Metabolic Dysregulation in Dyads [NA]
This clinical trial update shows ongoing recruitment for a University of South Carolina study focused on reducing metabolic dysregulation in…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Improving Uptake of Bowel Cancer Screening Among South Asian Adults in Bradford [NA]
Clinical trial update on a study aiming to increase uptake of bowel cancer screening among South Asian adults in Bradford; the trial is curr…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
This document outlines an ongoing clinical trial evaluating immunomodulator-based combination therapies for colorectal cancer, which is curr…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Terminated clinical trial evaluating the clinical utility of selected circulating tumor DNA assays in patients with advanced malignancies, s…
-
EMA approval · 2026-01-28EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorised Abevmy (bevacizumab) as a biosimilar. It is approved for several cancer indications including colorectal, breast, ovarian, fa…
-
EMA approval · 2026-01-28EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG
EMA authorised Oyavas, a bevacizumab biosimilar by STADA, for multiple indications including colorectal, breast, ovarian, fallopian tube, pe…
-
EMA approval · 2026-01-28EMA Authorised: Vegzelma (bevacizumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Vegzelma, a bevacizumab biosimilar from Celltrion Healthcare Hungary Kft., for multiple cancers including colorectal, breast,…
-
EMA approval · 2026-01-28EMA Authorised: Aybintio (bevacizumab) — Samsung Bioepis NL B.V.
The EMA authorised Aybintio, a bevacizumab biosimilar from Samsung Bioepis NL B.V., for multiple cancer indications including colorectal, br…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer [Phase 1]
Phase 1 clinical trial evaluating a triple combination of regorafenib, ipilimumab, and nivolumab in chemotherapy-resistant microsatellite-st…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors [NA]
Duke University is recruiting for a study on symptom management and transitioning to engagement with post-treatment care for adolescent and …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study on the Efficacy of the Metaverse Lifestyle Health Education Model Based on the Transtheoretical Model for Improving Quality of Life and Modifying Lifestyle in Colorectal Cancer Survivors [NA]
A clinical trial protocol evaluating a metaverse-based lifestyle education model for improving quality of life in colorectal cancer survivor…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in combination with pembrolizumab for adults with various solid tumors that have failed …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
Expanded access program for Ulixertinib (BVD-523) in patients with advanced MAPK pathway-altered malignancies across multiple tumor types. T…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis [NA]
This entry reports a recruiting clinical trial evaluating adjuvant chemotherapy after preoperative therapy for locally advanced colorectal c…
-
EMA approval · 2026-01-28EMA Authorised: Erbitux (cetuximab) — Merck Europe B.V.
EMA authorised Erbitux (cetuximab) for head and neck cancer and colorectal cancer under Merck Europe B.V.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update indicates that TH9619 is being studied in a Phase 1/2 trial for advanced solid tumors, with recruitment ongoing a…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy [Phase 1, Phase 2]
This is an ongoing Phase 1/2 clinical trial evaluating a triple therapy of Botensilimab, Balstilimab, and Regorafenib in microsatellite-stab…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Early Onset Colorectal Cancer Detection
Ongoing clinical trial at City of Hope Medical Center is evaluating early detection methods for colorectal cancer and is currently recruitin…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
This clinical trial aims to evaluate exosome-derived liquid biopsy for detecting extrahepatic metastases in colorectal cancer patients with …
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…